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Abstract: Functional amyloids are important structural and functional components of many biofilms,
yet our knowledge of these fascinating polymers is limited to a few examples for which the native
amyloids have been isolated in pure form. Isolation of the functional amyloids from other cell
components represents a major bottleneck in the search for new functional amyloid systems. Here
we present a label-free quantitative mass spectrometry method that allows identification of amyloid
proteins directly in cell lysates. The method takes advantage of the extreme structural stability and
polymeric nature of functional amyloids and the ability of concentrated formic acid to depolymerize
the amyloids. An automated data processing pipeline that provides a short list of amyloid protein
candidates was developed based on an amyloid-specific sigmoidal abundance signature in samples
treated with increasing concentrations of formic acid. The method was evaluated using the Escherichia
coli curli and the Pseudomonas Fap system. It confidently identified the major amyloid subunit for both
systems, as well as the minor subunit for the curli system. A few non-amyloid proteins also displayed
the sigmoidal abundance signature. However, only one of these contained a sec-dependent signal
peptide, which characterizes most of all secreted proteins, including all currently known functional
bacterial amyloids.
Keywords: functional amyloids; biofilm; nanomaterials; mass spectrometry
1. Introduction
Amyloids are highly ordered protein fibrils defined by a cross-β-sheet quaternary structure and
the ability to self-assemble from their monomeric counterparts in a nucleation-dependent process [1].
Many amyloids display exceptional resistance towards thermal and chemical denaturants due to a
tightly packed cross-β structure [2]. Consequently, they are ideal structural materials in biological
systems, and organisms from all domains of life exploit amyloids for beneficial purposes [3,4].
Functional amyloids have also shown promising results as tunable nanomaterials. The well-described
Escherichia coli curli system was for example used to engineer biofilm properties by genetically attaching
functional domains from other proteins to the major amyloid subunit (CsgA) [5]. Another type of
amyloid that has shown potential applications as a nanomaterial is the hydrophobins expressed by
fungi. Hydrophobins have a special ability to position themselves at water-air or solid-water interfaces,
thus making them very applicable within protein purification. Furthermore, they show possibilities
within the food industry, in pharmaceuticals, and for biotechnological processes [6]. With the numerous
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possible applications of amyloids, it is of great interest to discover new amyloid systems from a variety
of different microorganisms.
Microbial biofilms represent bacteria embedded in an extracellular matrix (ECM) composed
mainly of polysaccharides, extracellular DNA, and proteins [7]. The ECM enables the bacteria
to organize spatially, which allows for functional differentiation [8,9]. It also provides protection
against environmental and chemical stresses, including the action of antibiotics and host immune
response. The biofilm lifestyle is accordingly favored by the majority of all bacteria [9], and biofilm
formation by pathogenic bacteria is tightly associated with the development of chronic infections [10].
Previous studies have indicated that amyloids are common components of almost all microbial
biofilms independent of habitat [11,12]. They are therefore believed to play essential roles in biofilm
ecology [13]. However, our current knowledge of functional amyloids is restricted to a few amyloid
systems, for which the amyloids have been purified and characterized in detail [4]. The identification
and characterization of more amyloid systems will likely provide a deeper insight into the many roles
of amyloids in biofilms.
Functional amyloid systems are traditionally discovered based on the isolation of native amyloids
and the validation of the amyloid structure through biophysical characterization. The isolation
of amyloids is unfortunately not a straightforward task. Insolubility and extreme stability, which
characterize most functional amyloids, exclude them from standard protein analyses, including
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and mass spectrometry-based
characterization without special pretreatment. Furthermore, many functional amyloids are highly
adhesive and therefore easily lost during purification due to binding to consumables such as pipet
tips and sample tubes. Consequently, the current methods require pure cultures, which can express
a large number of amyloids under laboratory conditions. A purification-independent technique for
amyloid protein identification would provide the means to identify less abundant amyloids, as well
as amyloids that are only expressed upon exposure to habitat-specific environmental cues, including
stress conditions and host defense mechanisms [14].
We here present a quantitative proteomics technique that facilitates the direct identification of
functional amyloid candidates in cell lysates. This technique is specific, sensitive, and provides
an opportunity to identify amyloids in complex samples with low bacterial diversity, such as
clinical biofilms.
2. Results
2.1. Description of the Method
An overview of the new method for amyloid detection is presented in Figure 1. The bacteria in
the sample are first lysed to release intracellular proteins. Next, aliquots of the total cell lysate are
lyophilized and treated with formic acid at concentrations ranging from 0% to 100%. Many functional
amyloids are only depolymerized in aggressive solvents such as concentrated formic acid [15,16],
trifluoroacetic acid (TFA) [17,18], or hexafluoroisopropanol (HFIP) [19]. Functional amyloids are
therefore only depolymerized in the samples treated with high concentrations of formic acid. The
samples are lyophilized again to remove water and formic acid, dissolved in a special reducing
SDS-PAGE loading buffer [20], and subjected to a brief run on an SDS-PAGE gel. The SDS-PAGE
has two purposes: it removes cell debris and the native amyloids that are not able to enter the gel,
and it retains the depolymerized amyloid proteins in an exposed monomeric conformation amenable
to proteolytic digestion. The gel-embedded proteins are subjected to in-gel tryptic digest, and the
resulting peptides are analyzed by mass spectrometry. Protein identification and quantification are
done using MaxQuant [21] with the label-free quantification (LFQ) algorithm [22]. The LFQ values
are normalized between individual measurements to prevent systematic errors such as deviations
in sample loading, and are based on at least two quantifiable peptides. This allows the relative
abundances of the same protein to be compared across samples. Amyloid proteins are suspected to
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show much higher abundance in samples treated with a higher concentration of formic acid, and they
will therefore produce a characteristic sigmoidal abundance signature when the relative abundance is
plotted against the formic acid concentration (Figure 1).
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into aliquots that are  lyophilized and treated with either 0%, 20%, 40%, 60%, 80%, or 100% formic 
acid. The samples are then lyophilized, dissolved in reducing sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS‐PAGE) loading buffer, and subjected to short run SDS‐PAGE. The amyloid 
proteins can only enter the gel if they have been pretreated with concentrated formic acid and are 
therefore only present  in  these  samples.  In‐gel digestion  is  carried out with  trypsin, and  samples 
analyzed by label‐free quantitative LC‐MS/MS using MaxQuant and the MaxLFQ algorithm. The data 
is finally analyzed for each protein using an automated script, and positive amyloid candidates are 
identified based on their abundance profiles with respect to the formic acid concentration. 
The mass spectrometry analysis results in the identification of thousands of proteins, and it is an 
enormous task to review the abundance signature for each protein. To ease this process, we created 
an R‐markdown script  that automatically  identifies  functional amyloid candidates based on  their 
abundance signatures (Script S1). The script uses the raw MaxQuant data as input and separates the 
data for each protein. It then normalizes the abundance data according to the sample with the highest 
concentration giving it a value of 1. The normalized data for each protein is then fitted to a generalized 
linear model of the logistic function: 
f(x) = 1/(1 + exp(−(a + bx))),  (1) 
The formic acid concentration where half of the amyloids have been depolymerized (f50) is: 
f50 = −a/b,  (2) 
The slope of the fit at f50 is calculated as: 
f’(f50) = b/4,  (3) 
We here define functional amyloids candidates as proteins that fulfill the following requirements: 
f50 > 60, 
f50 < 100, 
f’(f50) > 0.025 
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Figure 1. Direct identification f functional amyloid proteins using label-free quantit tive (LFQ) Liquid
chromatography–tandem mass spectrom try (LC-MS/MS). The sample is ly ed and divide into
aliqu ts that are lyophilized and treated with either 0%, 20%, 40%, 60%, 80%, or 100% formic a id.
The samples are then lyophilized, dissolved in reducing sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) loading buffer, and subjected to short run SDS-PAGE. The amyloid proteins
can only enter the gel if they have been pretreated with concentrated formic acid and are therefore
only present in these samples. In-gel digestion is carried out with trypsin, and samples analyzed by
label-free quantitative LC-MS/MS using MaxQuant and the MaxLFQ algorithm. The data is finally
analyzed for each protein using an automated script, and positive amyloid candidates are identified
based on their abundance profiles with respect to the formic acid concentration.
The mass spectrometry analysis results in the identification of thousands of proteins, and it is an
enormous task to review the abundance signature for each protein. To ease this process, we created
an R-markdown script that automatically identifies functional myloid ca didates based on their
abundance signatures (Script S1). The script uses the raw M xQua t da a a input and separates he
data for each protein. It then normalizes the abundance data ccording to sample with the highest
concentrati n giving it a value of 1. The normalized data for each protein is then fitted to a generalized
linear model of the logistic function:
f(x) = 1/(1 + exp(−(a + bx))), (1)
The formic acid concentration where half of the amyloids have been depolymerized (f50) is:
f50 = −a/b, (2)
The slope of the fit at f50 is calculated as:
f’(f50) = b/4, (3)
We here define functional amyloids candidates as proteins that fulfill the following requirements:
f50 > 60,
f50 < 100,
f′(f50) > 0.025
(4)
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2.2. Method Validation with Cell Lysates of E. coli SM2258
The method was first evaluated with four biological replicates of the amyloid-producing E. coli
strain SM2258 [11] grown at conditions known to promote curli expression (Figure 2A). The curli
amyloids are composed of two subunits, the major subunit CsgA and the minor subunit CsgB [23].Biomolecules 2017, 7, 58    4 of 9 
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Figure 2. The identification of functional amyloid candidates in cell lysates of (A) Escherichia coli
SM2258 and (B) Pseudomonas sp. UK4. Proteins with amyloid-specific abundance signatures in at least
two biological replicates are shown with green titles. Negative controls are shown in red titles, which
include the household proteins, Glyceraldehyde-3-phosphate dehydrogenase A (GapA) and 60 kDa
chaperonin (GroEL); and β-barrel outer membrane proteins, like outer membrane protein A (OmpA)
and antigen 43 (Ag43). The numbers in the parentheses indicate the number of biological replicates
in which the proteins were classified as amyloid candidates based on the fitting parameters. Notice
that some data points and curves are hidden as they overlap, and some proteins were not observed in
all replicates.
Mass spectrometry analysis identified a total of 1438 proteins (Figure S1), of which 56 were
classified as functional amyloid candidates (Table S1). However, many of the identified candidates were
low abundant proteins that were only supported by data from a single biological replicate. To remove
false positive hits, only pr teins that were identified as amyloids i at least two of t e replicates were
considered. This reduced the list of amyloid candidates to ight (Figure 2). All currently known
function bacterial amyloids co tain Sec-dependent signal peptides that mark them for secretion.
The identified candidates were therefore analyzed for the presence of sec-dependent signal peptides
using the SignalP 4.1 algorithm [24] (Table S1). Only two of the eight amyloid candidates contained
Sec-dependent signal peptides, namely the major (CsgA) and the minor (CsgB) curli amyloid subunits.
These two proteins were also the only proteins identified as amyloid candidates in all four biological
replicates, demonstrating the specificity and sensitivity of the method.
2.3. Method Validation with Cell Lysates of Pseudomonas sp. UK4
To further evaluate the method, we analyzed three biological replicates of Pseudomonas sp. UK4
grown at conditions know to promote functional amyloid f Pseudomonas (Fap) xpression [16]
(Figure 2B). The Fap amyloids are composed of the major subunit FapC and the minor subunit
FapB [16]. A third protein FapE has also been observed in the purified preparations of Fap fibrils, but
it is uncertain if this protein is an integrated part of the amyloid [20]. Pseudomonas sp. UK4 produce
significantly less amyloid compared to E. coli SM2258, and is likely a better model for other wild-type
strains producing amyloids.
Mass spectrometry analysis identified a total of 2309 proteins (Figure S2), of which 46 were
classified as functional amyloid candidates (Table S2). Only six of these were supported by data from
at least two replicates. Two of these proteins contained Sec-dependent signal peptides according
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to SignalP 4.1 analysis. One was the major functional amyloid subunit (FapC), the other was a
low abundant glutamine ABC transporter substrate-binding protein (HZ99_18940). Only FapC was
identified in all three biological replicates. The minor amyloid subunit (FapB) was not detected in the
mass spectrometry data due to low abundance. The confident detection of FapC as an amyloid protein,
even though it was expressed at a significantly lower level than the E. coli curli, confirms the specificity
and sensitivity of the method.
3. Discussion
The isolation of functional amyloids from other cell components represents a major obstacle in the
identification of new functional amyloid systems [4]. The method described here allows identification
of functional amyloid proteins directly in cell lysates without any purification steps. It thus provides an
opportunity to screen for amyloids in systems, where it is difficult or impossible to separate the native
amyloids from contaminating cell components. By applying the method to two evolutionarily distinct
amyloid systems, it was shown that the method is both sensitive and specific. The method returned
only a few false positive amyloid candidates when biological replicates were considered, and the
number of false positives could easily be reduced based on the presence or absence of Sec-dependent
signal peptides, which characterizes all currently described functional bacterial amyloid proteins.
However, cell lysis products are known to play important roles in biofilm structure and function, and
it is possible the cytosolic proteins released may form amyloids when exposed to the extracellular
environment. Such amyloids would be missed with the signal peptide criterion.
Another problem with the identification of novel functional amyloid systems relies on the fact
that many bacteria require specific environmental stimuli to activate amyloid expression [25]. Such
stimuli may involve interaction with host surface molecules, or they may be too complex to replicate in
the laboratory. However, the current method may provide a solution to this problem. Due to the high
sensitivity of the method, it may allow for the identification of amyloids directly in complex samples
such as environmental biofilms or in cocultures of bacteria and their hosts.
We have previously hypothesized that many biofilm-forming pathogenic bacteria may use
amyloid proteins during infections [26,27]. Now we can test this hypothesis by applying the current
method to samples obtained from chronic wounds of immune-impaired individuals or sputum samples
from patients suffering from cystic fibrosis. If amyloids are identified as important virulence factors,
they may be targeted with specific or more general inhibitors, represented by CsgC for E. coli [28] and
epigallocatechin gallate (EGCG) for Pseudomonas Fap [29], respectively.
It should be stressed that the method itself cannot be used to confirm whether a protein is an
amyloid component. This still requires biophysical characterization of the native amyloid fibrils.
However, with the current method and access to genomes or the relevant strains, we can identify
the operons encoding the amyloids. These operons may then be expressed in bacteria that allow
purification of the native amyloids, as has previously been done for the fap-operon from various
species of Pseudomonas [16,20]. Another limitation of the method is that it can only be used to identify
extremely stable amyloids that require more 50% formic acid to be depolymerized. The TasA amyloids
from Bacillus subtilis are known to be depolymerized already at 20% formic acid [30]. The method
will therefore not identify TasA as an amyloid protein. The current approach also misses proteins
that occur both in a soluble and an amyloid form within the same sample, e.g., the phenol soluble
modulins of Staphylococcus aureus. However, despite these limitations, we believe that the current
method will provide a useful tool for many working within the field of functional amyloids, and that
it will expedite the identification of future functional amyloid systems.
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4. Materials and Methods
4.1. Bacterial Cultures and Activated Sludge
Glycerol stocks of E. coli MG1665 str. SM2258 [11] and Pseudomonas sp. UK4 [16,31] were used to
inoculate 10 mL of colonization factor antigen (CFA) medium (10 g/L hydrolyzed casein, 50 mg/L
MgSO4, 5 mg/L MnCl2, 1.5 g/L yeast extract, pH 7.4) in 50-mL Greiner tubes. The bacteria were grown
overnight at 26 ◦C with 150 rpm of agitation in an Innova 40 Benchtop Incubator Shaker (Eppendorf,
Hamburg, Germany). Then, 100 µL aliquots of each overnight culture were spread on 10 CFA agar
plates solidified with 2% agar, which were incubated at 26 ◦C for 72 h. Bacteria from 10 plates were
scraped off and resuspended in 10 mL buffer (10 mM Tris-HCl, pH 8.0).
4.2. Sample Preparation for Mass Spectrometry
For sample preparation, 4× 1 mL of bacterial culture were transferred to lysing matrix E tubes (MP
Biomedicals, Eschwege, Germany). Subsequently, 10 µL of Halt protease and phosphatase inhibitor
cocktail (ThermoFisher Scientific, Waltham, MA, USA) were added to each tube to prevent protein
degradation during cell lysis. The samples were then lysed by bead beating in a FastPrep-24 instrument
for 3 × 20 s at 6.0 m/s. The samples were incubated on ice for 2 min between each bead beating to
prevent thermally induced protein denaturation. Beads were allowed to settle by gravity for 5 min,
after which 500 µL cell lysate were collected from the four tubes and combined. Then, 50 µL aliquots
of the cell lysate were transferred to six Eppendorf tubes in three or four replicates. The replicates were
lyophilized and resuspended in 100 µL of either 0%, 20%, 40%, 60%, 80% or 100% formic acid. The
samples were lyophilized again and then resuspended in 100 µL of reducing SDS-PAGE loading buffer
containing 8 M of urea [20]. Insoluble material was pelleted by centrifugation for 1 min at 22,000× g,
and 15 µL of supernatant was loaded on 12% SDS-PAGE gels. Electrophoresis was carried out at 140 V
for 5 min, and the gels were stained with Coomassie Brilliant Blue G250 (ThermoFisher Scientific). The
narrow bands containing all proteins were excised and subjected to tryptic in-gel digestion [32]. Tryptic
peptides were reconstituted in 5% formic acid and purified using StageTips packed with PorosOligo
R3 material (Applied Biosystems, Foster City, CA, USA) on top of two C18 disks (3 M, Bioanalytical
Technologies, St. Paul, MN. USA) as previously described [33,34]. Peptides were eluted with 66% (v/v)
acetonitrile (ACN) and dried by vacuum centrifugation without heating.
4.3. Mass Spectrometry
Ultra-performance liquid chromatography (UPLC) tandem mass spectrometry analysis was
performed on an ultimate 300 UPLC system (ThermoFisher Scientific) coupled online to a Q Exactive
Plus mass spectrometer (ThermoFisher Scientific). Desalted peptides were reconstituted in 0.1%
trifluoroacetic acid and 2% acetonitrile. Of each sample, 8 µL were injected by the autosampler and
concentrated on a trapping column (Pepmap100, C18, 100 µm × 2 cm, 5 µm, ThermoFisher Scientific)
with water containing 0.1% formic acid and 2% ACN at flow rates of 4 µL min−1. After 5 min, the
peptides were loaded onto a separation column (PepmapRSLC, C18, 75 µm i.d. × 75 cm, 100 Å,
ThermoFisher Scientific). Chromatography was performed with 0.1% formic acid in solvent A (100%
water) and B (100% acetonitrile) using a ramp gradient. The concentration of B was increased from 2%
to 8% over 1 min, followed by an increase from 8% to 30% over 39 min. Solvent B was subsequently
increased from 30% to 90% within 5 min and maintained at this level for 3 min.
The mass spectrometry proteomics data was deposited to the ProteomeXchange Consortium via
the PRIDE [35] partner repository with the dataset identifier PXD006835.
4.4. Data Analysis
Protein identification and quantification were done with the open-source software MaxQuant
v1.5.8.3 [21]. The sequence databases for E. coli str. K-12 MG1655 and Pseudomonas sp. UK4 were
retrieved from the National Center for Biotechnology Information (NCBI) (tax: 511145 and 452680) [36].
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Besides the standard settings, LFQ [22] was activated in MaxQuant. This included a peptide and
protein false discovery rate of 1%. Reversed sequences as decoys and contaminant sequences were
added automatically by MaxQuant. The minimum ratio count for LFQ was set to one. Complete
lists of the protein and peptide identifications, as well as detailed parameters, are available together
with the deposited mass spectrometric data. The reverse and contaminant sequences were removed
from the MaxQuant output, and unique identifiers (gene names or id numbers) were created for each
protein. The resulting dataset was loaded into R and analyzed using an automated R-markdown script
(Script S1).
Supplementary Materials: The following are available online at www.mdpi.com/2218-273X/7/3/58/s1,
Figure S1: Abundance profiles for all proteins in the E. coli SM2258 sample, Figure S2: Abundance profiles
for all proteins in the Pseudomonas sp. UK4 sample, Table S1: Amyloid candidates identified in the E. coli SM2258
sample, Table S2: Amyloid candidates identified in the Pseudomonas sp. UK4 sample, Script S1: R-markdown
script used for automated identification of amyloid protein candidates.
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